Genenta Science (GNTA) Short Interest Ratio & Short Volume $4.19 -0.11 (-2.56%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends Genenta Science Short Interest DataCurrent Short Interest4,300 sharesPrevious Short Interest4,100 sharesChange Vs. Previous Month+4.88%Dollar Volume Sold Short$14,878.00Short Interest Ratio0.3 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares18,220,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume14,078 sharesAverage Trading Volume9,115 sharesToday's Volume Vs. Average154% Short Selling Genenta Science ? Sign up to receive the latest short interest report for Genenta Science and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNTA Short Interest Over TimeGNTA Days to Cover Over TimeGNTA Percentage of Float Shorted Over Time Ad Colonial MetalsThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Retirement Protection Kit, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.Click here to get your free copy today. Genenta Science Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20244,300 shares $14,878.00 +4.9%N/A0.3 $3.46 6/30/20244,100 shares $12,710.00 -18.0%N/A1 $3.10 6/15/20245,000 shares $16,186.50 +47.1%N/A1.2 $3.24 5/31/20243,400 shares $11,662.00 +79.0%N/A0.6 $3.43 5/15/20241,900 shares $6,080.00 -60.4%N/A0.3 $3.20 4/30/20244,800 shares $14,784.00 +23.1%N/A0.8 $3.08 Get the Latest News and Ratings for GNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. 4/15/20243,900 shares $13,123.50 +30.0%N/A0.7 $3.37 3/31/20243,000 shares $10,500.30 -9.1%N/A0.7 $3.50 3/15/20243,300 shares $12,870.00 -5.7%N/A0.8 $3.90 2/29/20243,500 shares $15,399.65 -5.4%N/A1.2 $4.40 2/15/20243,700 shares $14,800.00 +5.7%N/A1.3 $4.00 1/31/20243,500 shares $14,105.00 -5.4%N/A1.3 $4.03 1/15/20243,700 shares $16,465.00 No ChangeN/A1.8 $4.45 12/31/20233,700 shares $18,315.00 -32.7%N/A1.7 $4.95 12/15/20235,500 shares $27,610.00 +14.6%N/A2.5 $5.02 11/30/20234,800 shares $23,760.00 -35.1%N/A2.4 $4.95 11/15/20237,400 shares $38,480.00 +37.0%N/A3.9 $5.20 10/31/20235,400 shares $28,836.00 -25.0%N/A3.2 $5.34 10/15/20237,200 shares $40,248.00 +1.4%N/A3.8 $5.59 9/30/20237,100 shares $36,565.00 +10.9%N/A4.4 $5.15 9/15/20236,400 shares $36,032.00 -1.5%N/A3.6 $5.63 8/31/20236,500 shares $37,700.00 -17.7%N/A3.2 $5.80 8/15/20237,900 shares $43,687.00 +9.7%N/A3.4 $5.53 7/31/20237,200 shares $39,168.00 +50.0%N/A3 $5.44 7/15/20234,800 shares $28,560.00 -14.3%N/A2.2 $5.95 6/30/20235,600 shares $32,984.00 +7.7%N/A2.7 $5.89 6/15/20235,200 shares $29,848.00 +300.0%N/A2.4 $5.74 5/31/20231,300 shares $7,932.73 -23.5%N/A0.5 $6.10 5/15/20231,700 shares $9,537.00 +54.6%N/A0.7 $5.61 4/30/20231,100 shares $6,600.00 +266.7%N/A0.4 $6.00 4/15/2023300 shares $1,890.00 No ChangeN/A0.1 $6.30 3/31/2023300 shares $1,725.00 -40.0%N/A0.1 $5.75 3/15/2023500 shares $3,350.00 -66.7%N/A0.1 $6.70 2/28/20231,500 shares $9,750.00 +114.3%N/A0.3 $6.50 2/15/2023700 shares $4,585.00 -22.2%N/A0.2 $6.55 1/31/2023900 shares $5,526.00 -50.0%N/A0.2 $6.14 1/15/20231,800 shares $11,610.00 -30.8%N/A0.4 $6.45 12/30/20222,600 shares $14,300.00 +116.7%N/A0.6 $5.50 12/15/20221,200 shares $6,780.00 +140.0%N/A0.4 $5.65 11/30/2022500 shares $2,605.00 -80.8%N/A0.2 $5.21“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 11/15/20222,600 shares $10,816.00 +225.0%N/A1.2 $4.16 10/31/2022800 shares $3,520.00 +33.3%N/A0.4 $4.40 10/15/2022600 shares $2,742.00 -25.0%N/A0.3 $4.57 9/30/2022800 shares $3,983.92 -11.1%N/A0.3 $4.98 9/15/2022900 shares $4,719.33 +125.0%N/A0.3 $5.24 8/31/2022400 shares $2,368.00 -71.4%N/A0.1 $5.92 8/15/20221,400 shares $8,876.00 -12.5%N/A0.4 $6.34 7/31/20221,600 shares $10,512.00 -46.7%N/A0.3 $6.57 7/15/20223,000 shares $20,220.00 No ChangeN/A0.6 $6.74 GNTA Short Interest - Frequently Asked Questions What is Genenta Science's current short interest? Short interest is the volume of Genenta Science shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 4,300 shares of GNTA short. Learn More on Genenta Science's current short interest. Is Genenta Science's short interest increasing or decreasing? Genenta Science saw a increase in short interest in July. As of July 15th, there was short interest totaling 4,300 shares, an increase of 4.9% from the previous total of 4,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genenta Science's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Genenta Science: Sutro Biopharma, Inc. (4.52%), Scilex Holding (6.98%), MeiraGTx Holdings plc (2.44%), Adaptimmune Therapeutics plc (2.55%), SOPHiA GENETICS SA (0.17%), Tenaya Therapeutics, Inc. (6.73%), Zura Bio Limited (5.41%), Molecular Partners AG (0.18%), Monte Rosa Therapeutics, Inc. (6.70%), Caribou Biosciences, Inc. (14.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Genenta Science stock? Short selling GNTA is an investing strategy that aims to generate trading profit from Genenta Science as its price is falling. GNTA shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genenta Science? A short squeeze for Genenta Science occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNTA, which in turn drives the price of the stock up even further. How often is Genenta Science's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNTA, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Sutro Biopharma Short Squeeze Scilex Short Squeeze MeiraGTx Short Squeeze Adaptimmune Therapeutics Short Squeeze SOPHiA GENETICS Short Squeeze Tenaya Therapeutics Short Squeeze Zura Bio Short Squeeze Molecular Partners Short Squeeze Monte Rosa Therapeutics Short Squeeze Caribou Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNTA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.